Pharmaceutical

FDA advisers recommend approval of monoclonal antibody ...

An FDA advisory committee voted overwhelmingly to recommend approval of a monocl...

Listen: Merck v. USA, the best of ASCO, and Leqembi at ...

Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer's...

STAT+: Top Senate Republican signals interest in site-n...

The House GOP wants to pursue hospital payment reforms that could cost hospitals...

STAT+: Study finds supplements of amino acid taurine sl...

Fifty years after a historic study on taurine, a new paper finds supplements of ...

AI insight at BIO, Google and Mayo Clinic’s latest effo...

In the latest edition of STAT's Health Tech newsletter: AI insight at BIO, Googl...

STAT+: If AI invents a new medicine, who gets the patent?

Pharma and biotech companies are increasingly using AI to discover and make medi...

STAT+: Pharmalittle: FDA commish calls U.S. drug prices...

FDA Commissioner Robert Califf told a crowd of biotech leaders at the BIO conven...

Here’s why obesity grew so quickly worldwide, and where...

In high-income countries, such as the U.S., the rate of increase in BMI has actu...

Opinion: Why brain decoding is not mind reading — and w...

It is never too early to think about the ethical issues that can arise from any ...

Eli Lilly achieving significant gains in obesity results

The recent rallying of Lilly’s market value has come as the result of two major ...

US FDA expands approval for Merck’s PREVYMIS (letermovir)

The FDA approval was supported by a double-blind, active comparator-controlled n...

EC grants marketing authorisation for Fennec’s Pedmarqsi

The regulatory approval comes after a positive opinion issued by the European Me...

AstraZeneca ends Phase IV Andexxa trial after positive ...

The company will now seek full-label approval for the bleeding reversal agent in...

EU agencies back Covid-19 vaccine update ahead of autum...

Two EU agencies issued a statement on Covid-19 vaccine composition changes to in...

Baudax Bio reports promising additional data for neurom...

Shares rose for the company following data that favourably compares high-dose BX...

ZyVersa Therapeutics inches closer to European patent a...

VAR 200 reduces renal cholesterol and the lipid accumulation that damages the fi...